VALANX
ID: 5300085VALANX is a site-specific protein conjugation platform founded in 2017 by Michael Lukesch.
2
Funding Rounds
$5.9m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** Lu***** |
|
- | |
| Pa**** Fl******** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company VALANX has raised a total of $5.9m in funding over 2 rounds.
Key Insights:
- VALANX Venture Round, March 2026: $3.5m
- VALANX Biotech November 2023 Seed Funding Round: $2.4m
Industries
VALANX is active in the following industries: